Suven Performance
Day's Low
Day's High
₹133.5Day's Price Range₹140.3552 Week's Low
52 Week's High
₹82.9552-Week Price Range₹169.3
| Returns % | |
| 1 Month Return | + 0.86 % |
| 3 Month Return | + 10.32 % |
| 1 Year Return | + 17.24 % |
| Market Stats | |
| Previous Close | ₹135.88 |
| Open | ₹137.49 |
| Volume | 3.32L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,963.19Cr |
Suven Key Statistics
| P/E Ratio | -20.28 |
| PEG Ratio | 21.35 |
| Market Cap | ₹2,963.19 Cr |
| P/B Ratio | 2.57 |
| EPS | -4.82 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | -2.36 |
Suven Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,963.19 Cr | 158.79% | 0.50 | -₹106 Cr | ₹11 Cr | |
| NA | ₹1,194.54 Cr | 76.56% | 0.68 | NA | NA | |
| BUY | ₹26,559.75 Cr | 51.37% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹25,422.62 Cr | 173.75% | 0.55 | ₹258 Cr | ₹1,375 Cr | |
| NA | ₹73.99 Cr | 31.49% | 0.56 | -₹2 Cr | ₹39 Cr |
About Suven
Share Price: ₹136.30 per share as on 20 Jan, 2025 04:01 PM
Market Capitalisation: ₹2,963.19Cr as of today
Revenue: ₹2.57Cr as on September 2024 (Q3 24)
Net Profit: ₹-49.64Cr as on September 2024 (Q3 24)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
| Organisation | Suven |
| Headquarters | Hyderabad |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Suven Life Sciences Ltd
Suven Life Sciences Shares Surge on Trial Progress - 08 Jan, 2025
Suven Life Sciences shares rose significantly after the company announced the dosing of first subjects in a Phase-1 clinical trial for SUVN-I6107, a drug targeting cognitive disorders. The stock closed 10.27% higher, reflecting positive investor sentiment following the FDA-approved trial update.
Insights on Suven Life Sciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, SUVEN stock has moved up by 6.1%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 5.01 Cr → 6.61 Cr (in ₹), with an average increase of 24.2% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 65.5%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 28.34% of holdings in Dec 2024 quarter
- NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.34% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 35.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.27% of holdings in Dec 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -26.54 Cr → -49.64 Cr (in ₹), with an average decrease of 41.3% per quarter
Suven Financials
Index Inclusions
Suven Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 70.27% | 0.00 | |
| Foreign Institutions | 0.34% | ||
| Mutual Funds | 1.05% | 0.03 | |
| Retail Investors | 28.34% | 0.00 | |
| Others | 0% |
Suven Key Indicators
Suven Valuation
Suven in the last 5 years
Lowest (-165.11x)
February 27, 2020
Today (-20.28x)
January 17, 2025
Industry (97.73x)
January 17, 2025
Highest (-6.67x)
March 27, 2023
Suven Earnings and Dividends
Suven Life Sciences Ltd Earnings Results
Suven Life Sciences Ltd’s net profit fell -291.48% since last year same period to ₹-49.64Cr in the Q2 2024-2025. On a quarterly growth basis, Suven Life Sciences Ltd has generated -77.03% fall in its net profits since last 3-months.
Read More about Earnings ResultsSuven Life Sciences Ltd Dividends February,2019
In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 - translating a dividend yield of 1.10%.
Read More about Dividends
Suven Technicals Summary
Bearish
Neutral
Bullish
Suven Life Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Suven Life Sciences Ltd
Suven Life Sciences Ltd share price today stands at ₹136.3, Open. ₹137.49 ; Previous Close. ₹135.88 ; High. ₹140.35 ; Low. ₹133.5 ; 52 Week High. ₹169.3 ; 52 Week Low: ₹82.95.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Suven Life Sciences Ltd shares.
Suven Life Sciences Ltd is listed on NSE
Suven Life Sciences Ltd is listed on BSE
- Today’s highest price of Suven Life Sciences Ltd is ₹140.35.
- Today’s lowest price of Suven Life Sciences Ltd is ₹133.5.
PE Ratio of Suven Life Sciences Ltd is -20.28
PE ratio = Suven Life Sciences Ltd Market price per share / Suven Life Sciences Ltd Earnings per share
Today’s traded volume of Suven Life Sciences Ltd(SUVEN) is 3.32L.
Today’s market capitalisation of Suven Life Sciences Ltd(SUVEN) is ₹2963.19Cr.
| Suven Life Sciences Ltd(SUVEN | Price |
|---|---|
52 Week High | ₹169.3 |
52 Week Low | ₹82.95 |
Suven Life Sciences Ltd(SUVEN) share price is ₹136.3. It is down -19.49% from its 52 Week High price of ₹169.3
Suven Life Sciences Ltd(SUVEN) share price is ₹136.3. It is up 64.32% from its 52 Week Low price of ₹82.95
| Suven Life Sciences Ltd(SUVEN | Returns |
|---|---|
1 Day Returns | 0.42% |
1 Month Returns | 0.86% |
3 Month Returns | 10.32% |
1 Year Returns | 17.24% |